Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Johnson & Johnson JNJ

• Dividend Yield: 3.06%
• Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $170 to $169 on Jan. 24, 2024. This analyst has an accuracy rate of 67%.
• Raymond James analyst Jayson Bedford maintained an Outperform rating and boosted the price target from $172 to $175 on Jan. 3, 2024. This analyst has an accuracy rate of 67%.
• Recent News: Johnson & Johnson is reportedly in talks to acquire Shockwave Medical, Inc SWAV.

Patterson Companies, Inc. PDCO

• Dividend Yield: 3.85%
• Morgan Stanley analyst Erin Wright maintained an Equal-Weight rating and cut the price target from $38 to $35 on Nov. 30, 2023. This analyst has an accuracy rate of 77%.
• Stifel analyst Jonathan Block reiterated a Hold rating with a price target of $32 on Nov. 28, 2023. This analyst has an accuracy rate of 77%.
• Recent News: On March 11, Patterson Companies approved a $500 million stock buyback and declared a quarterly dividend of 26 cents per share.

Gilead Sciences, Inc. GILD

• Dividend Yield: 4.25%
• Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and cut the price target from $84 to $77 on March 4, 2024. This analyst has an accuracy rate of 76%.
• RBC Capital analyst Brian Abrahams maintained a Sector Perform rating and lowered the price target from $76 to $75 on Feb. 14, 2024. This analyst has an accuracy rate of 71%.
• Recent News: On March 22, Gilead Sciences announced completion of acquisition of CymaBay.

Read More: GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session